about
Survival of airborne MS2 bacteriophage generated from human saliva, artificial saliva, and cell culture mediumThe role of crude saliva and purified salivary mucins in the inhibition of the Human Immunodeficiency Virus type 1Salivary defense proteins: their network and role in innate and acquired oral immunityThe calcium-induced conformation and glycosylation of scavenger-rich cysteine repeat (SRCR) domains of glycoprotein 340 influence the high affinity interaction with antigen I/II homologs.Design aspects of a case-control clinical investigation of the effect of HIV on oral and gastrointestinal soluble innate factors and microbes.Prediction of Intrinsic Disorder in MERS-CoV/HCoV-EMC Supports a High Oral-Fecal Transmission.An electrochemiluminescence assay for gp340 (DMBT1).Oropharyngeal mucosal transmission of Zika virus in rhesus macaques.Diverse functions of defensins and other antimicrobial peptides in periodontal tissues.Increased expression of deleted in malignant brain tumors (DMBT1) gene in precancerous gastric lesions: Findings from human and animal studies.Short communication: HIV type 1 escapes inactivation by saliva via rapid escape into oral epithelial cells.Human ezrin-moesin-radixin proteins modulate hepatitis C virus infection.Mechanical Barriers Restrict Invasion of Herpes Simplex Virus 1 into Human Oral Mucosa.Salivary Blockade Protects the Lower Respiratory Tract of Mice from Lethal Influenza Virus Infection.Shell disorder, immune evasion and transmission behaviors among human and animal retroviruses.Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus?Staphylococcus aureus SasA is responsible for binding to the salivary agglutinin gp340, derived from human salivaSusceptibility of human and avian influenza viruses to human and chicken saliva.The mouth and AIDS: the global challenge.Environmental Stability and Infectivity of Hepatitis C Virus (HCV) in Different Human Body Fluids.
P2860
Q23924199-47D724D3-B93A-4640-B575-F101D861F56BQ30420743-D3BBA29D-A5F6-45A5-B513-FB188C4F3AC6Q30467494-E6D739BC-EAAF-48A4-B619-9DBDF16661DAQ34070325-DAE48057-90E5-4556-9D1F-6BE58CC4C2B7Q34542852-2536DD38-B50F-4F13-B239-B209943B1439Q35051967-633C6287-3AEF-4B54-850D-177969580FB8Q37035535-45996F69-E7C5-4B3D-A086-83A326E8A8FCQ38157166-9B15A1B0-AFE5-49F5-9E86-DCF05C1FE8F6Q38562428-AF518CD8-8A3F-42F4-9D73-024174B78ECDQ38830215-B4772B6B-0A03-41ED-8D08-8B2D3B049E18Q38973203-CA8B2335-AB95-4891-B642-E83857DA1298Q39148009-CC91AB28-DA68-47DA-B8C5-9C711CF69A99Q40055002-95B6ADA6-B44F-4A05-8D1A-A496A5675546Q40226257-7D192179-C6C0-4A9F-AE38-7DC308056578Q41157592-92D89BF1-AE4B-4815-830A-7FE987FB3B1BQ41922735-4B296F91-F10A-4152-9101-50BB866A030CQ41985856-09DB316F-0B0F-465F-9264-0A30DE27BC2AQ42256536-93E33F70-7997-4732-B4C6-8FAD9AEF1FA6Q43800505-1FB612B4-3E41-489F-8678-C4318B1BA0C1Q55256500-FF823217-FA63-439D-AED7-B34B18371775
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Antiviral activities in human saliva
@ast
Antiviral activities in human saliva
@en
type
label
Antiviral activities in human saliva
@ast
Antiviral activities in human saliva
@en
prefLabel
Antiviral activities in human saliva
@ast
Antiviral activities in human saliva
@en
P2093
P2860
P356
P1476
Antiviral activities in human saliva
@en
P2093
P2860
P356
10.1177/0022034511399282
P577
2011-04-01T00:00:00Z